Soligenix Inc. Advances Treatment for Rare Behçet’s Disease with SGX945
Behçet’s disease, a rare autoimmune condition with prevalence estimates varying from 0.12 to 7.5 per 100,000 in the United States and Europe, presents significant challenges for those affected. The disease, which is believed to have both genetic and environmental components, manifests most severely in young adulthood, with symptoms that can include painful oral and genital […]